To bring disruptive technologies in health, environment and sustainable manufacturing to market.
Most of our team has advanced training in science and our Science Advisory Board is top-notch; We promote science-based pitch competitions to discover and support ambitious SynBio projects.
Spans many niche areas of SynBio research and commercialization across Europe. We nurture it through our Annual SynBio Day and other activities.
100% dedicated to investment in SynBio.
Our investments are at different stages of growth and span health, environment and sustainable manufacturing.
Synthetic biology and applies techniques from engineering and computer sciences to biology. We believe it will revolutionize how we live, eat, and protect our planet.
of the materials we use could be made using biological means
use cases spanning applications in healthcare, manufacturing, agriculture, energy and the environment
the value projection of direct economic impact of innovation in SynBio is estimated to be by 2040
We act as a bridge between academia and industry, financing and developing synthetic biology innovation across Europe, UK, and Israel through an innovative investment model geared towards very early-stage start-ups and more mature SynBio companies.
We’re convinced that the right SynBio innovations will provide solutions to major challenges of our time.
Stay up to date with our latest news and events.
The European project will enhance the commercial potential of one of today’s most disruptive fields
eureKARE announces EonBio as the second company to be supported by its Belgium biomedical start-up studio
Ms. Lauvergeon brings an extensive background in the management of large energy corporations (most notably as CEO of Areva), finance, and government.
Innovative gene circuit technology has the potential to detect and treat cancerous and other diseased cells​
Authored by eureKARE: Alexandre Mouradian (Chairman, Co-Founder and CEO)
Biomemory, founded in 2021, is positioned at the crossroads of Biotechnology and IT and is a key player in the DNA data storage space. Its ambition is to help meet the climate challenge posed by data centers.
